Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Type 2 diabetes
Pharma
Generic versions of Novo's semaglutide launch today in India
With patents for Novo Nordisk’s semaglutide expiring in India, more than 40 drugmakers will begin launching their cheaper copycats in the country.
Kevin Dunleavy
Mar 20, 2026 11:27am
China signs off on Pfizer, Sciwind's GLP-1 weight loss drug
Mar 6, 2026 11:22am
Pfizer snaps up rights to commercialize diabetes GLP-1 in China
Feb 24, 2026 11:15am
Europe's CHMP gives nods to Novo's Kyinsu, Bayer's Lynkuet
Sep 19, 2025 10:45am
Lilly's Mounjaro scores in Type 2 diabetes trial in kids 10-17
Sep 18, 2025 11:22am
Lilly pauses UK orders on its diabetes and obesity med Mounjaro
Aug 28, 2025 11:08am
